株式会社メディックス

EDINET

Annual consolidated revenue for 2026: about JPY 4.257B, using the latest reported figures.

Watchlist

Latest fiscal year

Revenue

4.26 billion JPY

2026 · JPY

Exact inputs and evidence
  • Revenue: 4256886000 JPY

Operating margin

15.49%

2026 · %

Exact inputs and evidence
  • Operating Income: 659413000 JPY
  • Revenue: 4256886000 JPY

Operating cash flow

253 million JPY

2026 · JPY

Exact inputs and evidence
  • Operating Cash Flow: 252733000 JPY

Free cash flow

217 million JPY

2026 · JPY

Exact inputs and evidence
  • Operating Cash Flow: 252733000 JPY
  • Capital Expenditure: 35714000 JPY
Cash and cash equivalents
4.06 billion JPY
Exact value

4064327000 JPY

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-07-15.

Financial data available through: 2026-03-31.

Coverage by financial measure
  • Revenue: 1 of 11 periods available· newest 2026-03-31
  • Operating income: 1 of 11 periods available· newest 2026-03-31
  • Net income: 1 of 11 periods available· newest 2026-03-31
  • Operating cash flow: 1 of 11 periods available· newest 2026-03-31
  • Capital expenditure: 1 of 11 periods available· newest 2026-03-31
  • Total assets: 1 of 11 periods available· newest 2026-03-31
  • Total liabilities: 1 of 11 periods available· newest 2026-03-31
  • Current assets: 1 of 11 periods available· newest 2026-03-31
  • Current liabilities: 1 of 11 periods available· newest 2026-03-31
  • Cash and cash equivalents: 1 of 11 periods available· newest 2026-03-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2026 2025-04-01 – 2026-03-31

  • Revenue JPY 4.26 billion 100% of revenue
  • Operating costs Derived JPY 3.6 billion 85% of revenue
  • Operating income JPY 659.41 million 15% of revenue
  • Tax, interest and other Derived JPY 222.44 million 5.2% of revenue
  • Net income JPY 436.97 million 10% of revenue

Cash

  • Operating cash flow JPY 252.73 million 5.9% of revenue
  • Capital expenditure JPY 35.71 million 0.8% of revenue
  • Free cash flow Derived JPY 217.02 million 5.1% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2026 10%85%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2026 2025-04-01 – 2026-03-314256886000 3597473000 Derived 659413000 222443000 Derived 436970000 217019000 Derived
Source

Amounts are exact, in JPY.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

JPY 4.3B 2026
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.6B3.4B2.3B1.1B0.02026
Values and sources
Revenue values and source evidence
PeriodSeriesValue(JPY)Source evidence
2026Revenue4256886000
  • Revenue: 4256886000

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2026Year over yearNo prior comparable period
  • Revenue: 4256886000

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 15.5% 2026
Net margin 10.3% 2026
Free cash flow margin 5.1% 2026
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.16.7%12.5%8.4%4.2%0.0%2026
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2026Operating margin15.5%
  • Operating Income: 659413000
  • Revenue: 4256886000
2026Net margin10.3%
  • Net Income: 436970000
  • Revenue: 4256886000
2026Free cash flow margin5.1%
  • Revenue: 4256886000
  • Operating Cash Flow: 252733000
  • Capital Expenditure: 35714000

Operating cash flow

Cash generated by the company’s normal business operations.

JPY 252.7M 2026
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.273.0M204.7M136.5M68.2M0.02026
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(JPY)Source evidence
2026Operating cash flow252733000
  • Operating Cash Flow: 252733000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

JPY 217M 2026
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.234.4M175.8M117.2M58.6M0.02026
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(JPY)Source evidence
2026Free cash flow217019000
  • Operating Cash Flow: 252733000
  • Capital Expenditure: 35714000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

53.9% 2026
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.58%44%29%15%0%2026
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2026Liabilities / assets53.9%
  • Total Liabilities: 4168777000
  • Total Assets: 7732233000

Current assets to current liabilities

Current assets divided by current liabilities.

2.19× 2026
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.37×1.78×1.18×0.59×0.00×2026
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2026Current assets / current liabilities2.19×
  • Current Assets: 6746537000
  • Current Liabilities: 3077093000

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2026 2025-04-01 – 2026-03-31
JPY 436.97 million
Exact value

Exact value: 436970000 JPY

2025-04-01 – 2026-03-31: 436970000 JPY Inspect Net Income
Share or cite

The citation records this snapshot. The page link may show a newer release later.

JPY 252.73 million
Exact value

Exact value: 252733000 JPY

2025-04-01 – 2026-03-31: 252733000 JPY Inspect Operating Cash Flow
Share or cite

The citation records this snapshot. The page link may show a newer release later.

JPY 35.71 million
Exact value

Exact value: 35714000 JPY

2025-04-01 – 2026-03-31: 35714000 JPY Inspect Capital Expenditure
Share or cite

The citation records this snapshot. The page link may show a newer release later.

JPY 217.02 million
Calculation and evidence

252733000 − 35714000 JPY

Exact free cash flow: 217019000 JPY

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Fund valuations

Fund series are shown separately from the manager’s corporate statements. The selected latest surface applies to both.

0 extracted fund blocks have no usable identified valuation.

No fund valuations are available for this selection.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

19 filings · 41 latest values · 41 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 331A0, 7010001030732, E40420, edinet:E40420

Also known as 株式会社メディックス